Displaying drugs 101 - 125 of 5058 in total
Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) hemagglutinin antigen (propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) hemagglutinin antigen (propiolactone inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (propiolactone inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Guangdong-Maonan/SWL1536/2019 CNIC-1909 (H1N1) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Guangdong-Maonan/SWL1536/2019 CNIC-1909 (H1N1) antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Hong Kong/2671/2019 NIB-121 (H3N2) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Hong Kong/2671/2019 NIB-121 (H3N2) antigen (UV, formaldehyde inactivated) …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen
Approved
Matched Synonyms: … Nimenrix component neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen …
Matched Name: … Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen …
Matched Name: … Neisseria meningitidis group W-135 capsular polysaccharide tetanus toxoid conjugate antigen …
Denileukin diftitox
A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.
Approved
Investigational
Matched Synonyms: … Interleukin-2/diptheria toxin fusion protein …
Matched Description: … A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin …
Matched Categories: … Recombinant Proteins …
Matched Description: … A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin …
Matched Categories: … Recombinant Proteins …
Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/North carolina/04/2016 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/North carolina/04/2016 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza B virus B/Singapore/INFTT-16-0610/2016 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza B virus B/Singapore/INFTT-16-0610/2016 hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Chikungunya vaccine (live, attenuated)
Chikungunya virus (CHIKV) is a member of the Alphavirus genus that was first identified in Tanzania in 1952. It is spread primarily by the bite of infected mosquitos of the Aedes genus. Infection with CHIKV causes chikungunya fever, an illness characterized by acute fever and severe, persistent arthralgia. Prior to...
Approved
Matched Synonyms: … Chikungunya virus LR2006 OPY1 (attenuated strain) antigen …
Matched Description: … [L48786] There are no approved treatments for active chikungunya virus infection. ... Chikungunya virus (CHIKV) is a member of the Alphavirus genus that was first identified in Tanzania in ... [A262051] Prior to 2013, chikungunya virus cases and outbreaks had been identified in countries in Africa …
Matched Description: … [L48786] There are no approved treatments for active chikungunya virus infection. ... Chikungunya virus (CHIKV) is a member of the Alphavirus genus that was first identified in Tanzania in ... [A262051] Prior to 2013, chikungunya virus cases and outbreaks had been identified in countries in Africa …
Bordetella pertussis toxoid antigen (glutaraldehyde inactivated)
Approved
Investigational
Matched Name: … Bordetella pertussis toxoid antigen (glutaraldehyde inactivated) …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA …
Matched Mixtures name: … ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN ... CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN ... (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA …
Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Poliovirus type 1 antigen (formaldehyde inactivated)
Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 1. The vaccine contains purified and inactivated poliovirus type 1 that were...
Approved
Investigational
Matched Name: … Poliovirus type 1 antigen (formaldehyde inactivated) …
Matched Description: … Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
Matched Description: … Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
Poliovirus type 2 antigen (formaldehyde inactivated)
Poliovirus type 2 antigen is a suspension of poliovirus Type 2 (MEF-1) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 2. The vaccine contains purified and inactivated poliovirus type 2 that were...
Approved
Investigational
Matched Name: … Poliovirus type 2 antigen (formaldehyde inactivated) …
Matched Description: … Poliovirus type 2 antigen is a suspension of poliovirus Type 2 (MEF-1) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
Matched Description: … Poliovirus type 2 antigen is a suspension of poliovirus Type 2 (MEF-1) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
Poliovirus type 3 antigen (formaldehyde inactivated)
Poliovirus type 3 antigen is a suspension of poliovirus Type 3 (Saukett) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 3. The vaccine contains purified and inactivated poliovirus type 3 that were...
Approved
Investigational
Matched Name: … Poliovirus type 3 antigen (formaldehyde inactivated) …
Matched Description: … Poliovirus type 3 antigen is a suspension of poliovirus Type 3 (Saukett) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
Matched Description: … Poliovirus type 3 antigen is a suspension of poliovirus Type 3 (Saukett) used in the active immunization …
Matched Mixtures name: … -POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE …
rsPSMA Vaccine
Prostate-specific membrane antigen (PSMA) is an ∼100 kDa transmembrane glycoprotein that is abundantly and preferentially expressed in prostate cancer, including recurrent and hormone-refractory cases. rsPSMA Vaccine is a subunit vaccine based on a novel rsPSMA protein that represents the entire extracellular domain of PSMA (Schulke et al., PNAS 100:12590, 2003)....
Approved
Investigational
Matched Synonyms: … Recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine …
Matched Description: … Prostate-specific membrane antigen (PSMA) is an ∼100 kDa transmembrane glycoprotein that is abundantly ... The vaccine comprises purified rsPSMA protein formulated with Alhydrogel® adjuvant. ... recurrent and hormone-refractory cases. rsPSMA Vaccine is a subunit vaccine based on a novel rsPSMA protein …
Matched Description: … Prostate-specific membrane antigen (PSMA) is an ∼100 kDa transmembrane glycoprotein that is abundantly ... The vaccine comprises purified rsPSMA protein formulated with Alhydrogel® adjuvant. ... recurrent and hormone-refractory cases. rsPSMA Vaccine is a subunit vaccine based on a novel rsPSMA protein …
Bordetella pertussis pertactin antigen (formaldehyde inactivated)
Approved
Matched Name: … Bordetella pertussis pertactin antigen (formaldehyde inactivated) …
Streptococcus pneumoniae type 23f capsular polysaccharide antigen
Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 23f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 23f capsular polysaccharide antigen …
Matched Description: … Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified …
Matched Description: … Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified …
Bacillus calmette-guerin substrain tice live antigen
Bacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis for percutaneous use. It is administered to prevent the development of tuberculosis.
Approved
Matched Name: … Bacillus calmette-guerin substrain tice live antigen …
Matched Description: … Bacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture …
Matched Description: … Bacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture …
Streptococcus pneumoniae type 9n capsular polysaccharide antigen
Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 9n of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Approved
Investigational
Matched Name: … Streptococcus pneumoniae type 9n capsular polysaccharide antigen …
Matched Description: … Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified …
Matched Description: … Streptococcus pneumoniae type 9n capsular polysaccharide antigen is a vaccine that contains highly purified …
Displaying drugs 101 - 125 of 5058 in total